About CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.
Industry, Sector and Symbol:
- Industry: N/A
- Sub-Industry: N/A
- Sector: Medical
- Symbol: OTCMKTS:CHPTY
- CUSIP: N/A
- Web: www.cspc.com.hk
- Debt-to-Equity Ratio: 0.02%
- Current Ratio: 1.95%
- Quick Ratio: 1.44%
Sales & Book Value:
- Trailing P/E Ratio: 38.57
- Forward P/E Ratio: 34.01
- P/E Growth: 1.17
- Annual Sales: $1.59338 billion
- Price / Sales: 7.68
- Cash Flow: $2.86 per share
- Price / Cash: 34.24
- Book Value: $10.84 per share
- Price / Book: 9.04
- Annual Dividend: $0.75
- Dividend Yield: 0.8%
- Trailing EPS: $2.54
- Net Income: $270.58 million
- Net Margins: 17.74%
- Return on Equity: 22.35%
- Return on Assets: 15.16%
- Employees: 10,023
- Outstanding Shares: 124,860,000
Frequently Asked Questions for CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
What is CSPC Pharmaceutical Group's stock symbol?
CSPC Pharmaceutical Group trades on the OTCMKTS under the ticker symbol "CHPTY."
When will CSPC Pharmaceutical Group make its next earnings announcement?
Who are some of CSPC Pharmaceutical Group's key competitors?
Some companies that are related to CSPC Pharmaceutical Group include C.R. Bard (BCR), Edwards Lifesciences Corporation (EW), Zimmer Biomet Holdings (ZBH), Incyte Corporation (INCY), Quintiles Transitional Holdings (IQV), Cerner Corporation (CERN), Align Technology (ALGN), Mylan N.V. (MYL), Sunny Optical Technology (Group) Company Limited (SNPTF), Lonza Group Ag (LZAGY), Cardinal Health (CAH), AmerisourceBergen Corporation (Holding Co) (ABC), Eisai (ESALY), Centene Corporation (CNC), Grifols, S.A. (GRFS), Coloplast A/S (CLPBY), Smith & Nephew SNATS (SNN) and DENTSPLY SIRONA (XRAY).
Who are CSPC Pharmaceutical Group's key executives?
CSPC Pharmaceutical Group's management team includes the folowing people:
- Dongchen Cai, Executive Chairman of the Board, Chief Executive Officer (Age 63)
- Weidong Pan, Executive Vice Chairman of the Board (Age 47)
- Kin Man Chak, Executive Director (Age 51)
- Hua Lu, Executive Director (Age 45)
- Jianmin Lu, Executive Director (Age 58)
- Huaiyu Wang, Executive Director (Age 53)
- Jinxu Wang, Executive Director (Age 46)
- Zhenguo Wang, Executive Director (Age 47)
- Ka Sze Lee, Company Secretary, Non-Executive Director (Age 57)
- Siu Keung Chan, Independent Non-Executive Director (Age 59)
How do I buy CSPC Pharmaceutical Group stock?
Shares of CSPC Pharmaceutical Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CSPC Pharmaceutical Group's stock price today?
One share of CSPC Pharmaceutical Group stock can currently be purchased for approximately $97.96.
How big of a company is CSPC Pharmaceutical Group?
CSPC Pharmaceutical Group has a market capitalization of $12.2316 billion and generates $1.59338 billion in revenue each year. The company earns $270.58 million in net income (profit) each year or $2.54 on an earnings per share basis. CSPC Pharmaceutical Group employs 10,023 workers across the globe.
How can I contact CSPC Pharmaceutical Group?
CSPC Pharmaceutical Group's mailing address is NO.226 HUANGHE STREET, SHIJIAZHUANG F4, 050035. The company can be reached via phone at 86-311-8703-7015 or via email at [email protected]
MarketBeat Community Rating for CSPC Pharmaceutical Group (OTCMKTS CHPTY)MarketBeat's community ratings are surveys of what our community members think about CSPC Pharmaceutical Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for CSPC Pharmaceutical Group (OTCMKTS:CHPTY) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
Analysts' Ratings History for CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for CSPC Pharmaceutical Group (OTCMKTS CHPTY)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for CSPC Pharmaceutical Group (OTCMKTS CHPTY)
Financials are not available for this stock.
CSPC Pharmaceutical Group (OTCMKTS CHPTY) Chart for Sunday, November, 19, 2017